Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex. Zhejiang Orient Gene Biotech Co., Ltd was founded in 2005 and is based in Huzhou, China.
Frequently asked questions
What sector does Zhejiang Orient Gene Biotech Co Ltd (688298) operate in?
Zhejiang Orient Gene Biotech Co Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Zhejiang Orient Gene Biotech Co Ltd (688298) current stock price?
As of the latest data, Zhejiang Orient Gene Biotech Co Ltd stock price is CN¥17.92, with a previous close of CN¥17.77. Zhejiang Orient Gene Biotech Co Ltd gained CN¥0.15 in the last trading session, representing a 0.84% increase.
What is Zhejiang Orient Gene Biotech Co Ltd (688298) current market capitalization?
Zhejiang Orient Gene Biotech Co Ltd market cap is approximately 3.61 billion.
What is Zhejiang Orient Gene Biotech Co Ltd (688298) Earnings Per Share (EPS)?
The trailing EPS is -CN¥3.30.
Does Zhejiang Orient Gene Biotech Co Ltd (688298) pay dividends?
No. Zhejiang Orient Gene Biotech Co Ltd does not pay a dividend.
What is Zhejiang Orient Gene Biotech Co Ltd (688298) beta (volatility) score?
Zhejiang Orient Gene Biotech Co Ltd has a beta of 0.828, meaning its volatility is roughly in line with the market.
